Clinical trial
Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia…
NCT00316732 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00316732 |
|---|---|
| Title | Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS |
| Official title | Observational Sutdy to Assess the Effectiveness of Avodart in Subjects With Benign Prostatic Hyperplasia in Day to Day Clinical Practice |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Procedure |
| Interventions | IPSS Questionnaire, EQ-5D Questionnaire |
| Enrollment | 173 |
| Start date | Oct 25, 2004 |
| Primary completion | Dec 19, 2006 |
| Completion | Dec 19, 2006 |
| First posted | Apr 21, 2006 |
| Last update posted | Oct 16, 2017 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: